Could CBD be the answer to helping reduce the symptoms of schizophrenia? The body has an endocannabinoid system. In fact, every mammal on the planet has one. This unique part of our body works with indigenous cannabinoids such as anandamide, serotonin, endorphins, and others. It also works with phytocannabinoids found in cannabis like THC, CBD, CBN, CBG, and others.
Phytocannabinoids cannot be created naturally by our body. The discovery of the endocannabinoid system has opened many doors for medical studies and treatments. One aspect of phytocannabinoids as a medical treatment is the potential of how CBD interacts with the body to control symptoms associated with schizophrenia.
The NCBI published a study called “Peripubertal cannabidiol treatment rescues behavioural and neurochemical abnormalities in the MAM model of schizophrenia” in which medical professionals investigated the effectiveness of CBD and how it works with treating the symptoms of schizophrenia.
The Study Conclusion
The studies you find on the NCBI commonly take place on laboratory animals such as rats and mice. This study is no different. However, you might need a medical degree to understand it.
It quotes things such as “At the molecular level, an increased cannabinoid receptor type-1 (CB1) mRNA and protein expression, which might be due to reduction in DNA methylation at the gene promoter in the prefrontal cortex (PFC), coincided with deficits in the social interaction test and in the novel object recognition test in MAM rats.”
Sufficient Evidence to End Prohibition
These type of studies are showing the future of what cannabinoid-based medicine could be. What it could be if the draconian view of cannabis were to continue to change and move forward towards the global prohibition of cannabis.
When you’re wrong, you’re wrong. For all of those lawmakers in America’s government who say we need more research, try typing NCBI into a browser and researching cannabis. There is an abundance of studies that offer more than sufficient evidence to end prohibition.
These studies are paving the way for the future of cannabinoid medicine. Others look at these studies and cry out why are we doing them on mice when there are so many people willing to participate?